RMD

ResMed Inc.
$246.20
+0.70 (+0.29%)
Mkt Cap 34.63B
Volume 873,492
52W Range 180.27-277.67
Sector Healthcare
Beta 0.75
EPS (TTM) 10.44 USD
P/E Ratio 23.58
Revenue (TTM) 5.65B USD
Rev Growth (5Y) +12.1%
EPS Growth (5Y) +26.1%
AlphaVal · Fair Value
What we estimate one share is worth
$203.76
Overvalued moderate signal
20.8% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
A
Platform & Compounding FCF
89.7 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 5.65B 5.15B 4.69B 4.22B 3.58B 3.20B 2.96B 2.61B 2.34B 2.07B 1.84B 1.68B
Net Income 1.52B 1.40B 1.02B 897.56M 779.44M 474.50M 621.67M 404.59M 315.59M 342.28M 352.41M 352.89M
EPS 10.44 9.55 6.94 6.12 5.34 3.27 4.31 2.83 2.21 2.42 2.51 2.51
Free Cash Flow 1.65B 1.66B 1.29B 559.30M 195.11M 619.89M 696.32M 381.71M 433.57M 342.58M 480.10M 311.24M
FCF / Share 11.40 11.33 8.75 3.81 1.34 4.27 4.82 2.67 3.04 2.42 3.42 2.22
Operating CF 1.81B 1.75B 1.40B 693.30M 351.15M 736.72M 802.25M 459.05M 505.03M 414.05M 547.93M 383.18M
Total Assets 8.97B 8.17B 6.87B 6.75B 5.10B 4.73B 4.59B 4.11B 3.06B 3.47B 3.26B 2.18B
Total Debt 825.92M 851.81M 873.93M 1.58B 917.55M 793.72M 1.30B 1.27B 281.45M 1.08B 1.17B 300.59M
Cash & Equiv 1.47B 1.21B 238.36M 227.89M 273.71M 295.28M 463.16M 147.13M 188.70M 821.93M 731.43M 717.25M
Book Value 6.59B 5.97B 4.86B 4.13B 3.36B 2.89B 2.50B 2.07B 2.06B 1.96B 1.69B 1.59B
Return on Equity 0.23 0.23 0.21 0.22 0.23 0.16 0.25 0.20 0.15 0.17 0.21 0.22
RMD News
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
Oct 19, 2026 04:00 AM · globenewswire.com
Top 50 High-Quality Dividend Growth Stocks For October 2026
Oct 11, 2026 08:46 AM · seekingalpha.com
ResMed (NYSE:RMD) CEO Sells $1,129,613.03 in Stock
Oct 11, 2026 01:39 AM · defenseworld.net
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
Oct 01, 2026 12:05 PM · globenewswire.com
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
Sep 22, 2026 02:03 AM · defenseworld.net
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
Sep 21, 2026 12:02 PM · marketbeat.com
Engineers Gate Manager LP Has $1.58 Million Stake in ResMed Inc. $RMD
Sep 17, 2026 12:13 AM · defenseworld.net
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
Sep 15, 2026 12:07 PM · barrons.com
Wall Street Lunch: AI Regulation Hopes Fade After Trump Calls AI Concerns A 'Hoax'
Sep 15, 2026 10:10 AM · seekingalpha.com
ResMed Inc. (RMD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Sep 15, 2026 09:11 AM · seekingalpha.com